Form 8-K - Current report:
SEC Accession No. 0001299933-10-001266
Filing Date
2010-03-29
Accepted
2010-03-29 16:46:04
Documents
6
Period of Report
2010-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_36926.htm 8-K 16541
2 EX-10.11 exhibit1.htm EX-10.11 20576
3 EX-10.12 exhibit2.htm EX-10.12 20746
4 EX-10.13 exhibit3.htm EX-10.13 20677
5 EX-10.15 exhibit4.htm EX-10.15 21279
6 EX-10.26 exhibit5.htm EX-10.26 20709
  Complete submission text file 0001299933-10-001266.txt   122133
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 10711107
SIC: 2834 Pharmaceutical Preparations